Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antony Kelly

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncotarget|April 9, 2017
Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicineDominique Barbolosi, Ilyssa Summer, Christophe Meille, et al.
Medicine|December 1, 2016
Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancerCamille Louvet, Annamaria De Bellis, Bruno Pereira, et al.
Molecular Genetics & Genomic Medicine|January 14, 2023
Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literatureGuilhaume Garrigues, Marie Batisse-Lignier, Nancy Uhrhammer, et al.
Frontiers in Medicine|March 8, 2021
Decision Tree With Only Two Musculoskeletal Sites to Diagnose Polymyalgia Rheumatica Using [<sup>18</sup>F]FDG PET-CTAnthime Flaus, Julie Amat, Nathalie Prevot, et al.
Annals of Clinical and Translational Neurology|November 28, 2018
Deep brain stimulation in five patients with severe disorders of consciousnessJean-Jacques Lemaire, Anna Sontheimer, Bruno Pereira, et al.
Frontiers in Medicine|September 14, 2020
Utility of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET/CTJulie Amat, Marion Chanchou, Louis Olagne, et al.
Endocrine|March 26, 2021
Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF networkFrançoise Bonichon, Thierry de Baere, Amandine Berdelou, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2018
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod)Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL TrialIsabelle Borget, Julia Bonastre, Bogdan Catargi, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncotarget|April 9, 2017
Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicineDominique Barbolosi, Ilyssa Summer, Christophe Meille, et al.
Medicine|December 1, 2016
Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancerCamille Louvet, Annamaria De Bellis, Bruno Pereira, et al.
Molecular Genetics & Genomic Medicine|January 14, 2023
Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literatureGuilhaume Garrigues, Marie Batisse-Lignier, Nancy Uhrhammer, et al.
Frontiers in Medicine|March 8, 2021
Decision Tree With Only Two Musculoskeletal Sites to Diagnose Polymyalgia Rheumatica Using [<sup>18</sup>F]FDG PET-CTAnthime Flaus, Julie Amat, Nathalie Prevot, et al.
Annals of Clinical and Translational Neurology|November 28, 2018
Deep brain stimulation in five patients with severe disorders of consciousnessJean-Jacques Lemaire, Anna Sontheimer, Bruno Pereira, et al.
Frontiers in Medicine|September 14, 2020
Utility of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET/CTJulie Amat, Marion Chanchou, Louis Olagne, et al.
Endocrine|March 26, 2021
Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF networkFrançoise Bonichon, Thierry de Baere, Amandine Berdelou, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2018
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod)Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL TrialIsabelle Borget, Julia Bonastre, Bogdan Catargi, et al.
Pageof 3